By Liz Szabo, Kaiser Health News Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure for the disease that has killed nearly 260,000 people remains a long way off — and might never arrive.
Hundreds of drugs are being studied around the world, but “I don’t see a lot of home runs right now,” said Dr. Carlos del Rio, a professor of infectious diseases at the Emory University Rollins School of Public Health. “I see a lot of strikeouts.” Researchers have launched more than 1,250 studies of COVID-19.
Pharmaceutical companies are investing billions to develop effective drugs and vaccines to help end the pandemic. Dr. Anthony Fauci, director of the National Institute of Allergy
Read more on themighty.com